PMA device
Nucleus® 22 Cochlear Implant System
Cochlear Americas · Implant, Cochlear (MCM, Class III) · First FDA decision Jan 16, 2001, newest Jul 3, 2025Hearing loss
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
15
PMA pathway
Device trials
7
Naming "Nucleus 22"
MAUDE reports
0
Brand "Nucleus 22", since 2015
PubMed studies
266
Mentioning "Nucleus 22"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Nucleus® 22 Cochlear Implant System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 15 decisions filed under this name.
FDA's records could not be loaded.
Older decisions: P890027-S049, P840024-S096, P840024-S092, P840024-S091, P840024-S085, P840024-S084, P840024-S082, P840024-S081, P840024-S080
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cochlear ImplantationNational analysisReview closedCAG-00107RUpdated Sep 17, 2026
- Cochlear ImplantationNational analysisReview closedCAG-00107NUpdated Sep 17, 2026
- Cochlear ImplantationNational determinationOn the books50.3Updated Mar 26, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Nucleus 22", any status and sponsor, newest update first.
Medical College of WisconsinAcademic, hospital or other
NCT04808323 · 22 participants (planned) · Start Jun 17, 2021 · Primary completion Apr 14, 2027
Device: Initial Dose of Radiation before Dose Escalation; Cohort A: Dose Escalation Radiation and 2 more · For: Rectal Adenocarcinoma
Sites: Milwaukee, Wisconsin
Alfred Chung, MDAcademic, hospital or other
NCT05486481 · 0 participants · Start Jan 8, 2024 · Primary completion Dec 31, 2028
Device: Cyclin D1 gene (CCDN1) /immunoglobulin heavy chain (IGH) fluorescence in situ hybridization (FISH) assay · For: AL Amyloidosis; Light Chain (AL) Amyloidosis; Systemic Light Chain Disease
Johannes Laengle, MD, PhDAcademic, hospital or other
NCT04488159 · 0 participants · Start Dec 1, 2024 · Primary completion Dec 1, 2025
Device: Immunoscore® assay · For: Colon Cancer Stage III
Sites: Vienna, Austria
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Nucleus 22", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MCM
51,927 reports: 19,701 malfunction, 32,181 injury, 22 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Nucleus 22"[tiab]. The summary above synthesizes these.
- Cochlear implant.
Fritsch JH, McCulloch BJ, Howe SW, et al. · Nebr Med J · 1991Review
- Cochlear reimplantation.
Woolford TJ, Saeed SR, Boyd P, et al. · Ann Otol Rhinol Laryngol Suppl · 1995Case Reports
- Cochlear implantation in otosclerosis.
Quaranta N, Bartoli R, Lopriore A, et al. · Otol Neurotol · 2005Evaluation Study
- Frequency mapping in cochlear implants.
Fu QJ, Shannon RV · Ear Hear · 2002Research Support, U.S. Gov't, P.H.S.
- Intracranial complications of cochlear implantation.
Dodson KM, Maiberger PG, Sismanis A · Otol Neurotol · 2007Case Reports
- Facial nerve stimulation from cochlear implants.
Bigelow DC, Kay DJ, Rafter KO, et al. · Am J Otol · 1998Review
- Adult porcine (Sus scrofa) derived inner ear cells: Characteristics in in-vitro cultures.
Wijesinghe P, Sastry A, Hui E, et al. · Anat Rec (Hoboken) · 2023Research Support, Non-U.S. Gov't
- Cerebral auditory plasticity and cochlear implants.
Manrique M, Cervera-Paz FJ, Huarte A, et al. · Int J Pediatr Otorhinolaryngol · 1999
- Mandarin tone recognition in cochlear-implant subjects.
Wei CG, Cao K, Zeng FG · Hear Res · 2004Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- The Ictal Signature of Thalamus and Basal Ganglia in Focal Epilepsy: A SEEG Study.
Pizzo F, Roehri N, Giusiano B, et al. · Neurology · 2021Research Support, Non-U.S. Gov't
- Vestibular stimulation by multichannel cochlear implants.
Bance ML, O'Driscoll M, Giles E, et al. · Laryngoscope · 1998Case Reports, Clinical Trial
- Cochlear implant candidate selection.
Pope ML, Miyamoto RT, Myres WA, et al. · Ear Hear · 1986Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code MCM.
- HiResolution Bionic Ear SystemAdvanced Bionics · PMA 2026
- Nucleus® 24 Cochlear Implant SystemCochlear Americas · PMA 2025
- COMBI 40+ Cochlear Implant SystemMed-El Corp. · PMA 2019
- Nucleus Cochlear Implant SystemsCochlear Americas · PMA 2022
- MED-EL Cochlear ImplantMed-El Corp. · PMA 2026
- Harmony Hiresolution Bionic Ear SystemAdvanced Bionics · PMA 2012
- Clarion Multi-Strategy Cochlear ImplantAdvanced Bionics · PMA 2026
- Nucleus 24 Auditory Brainstem ImplantCochlear Americas · PMA 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.